5 November, 2015 by The TZ Newswire Staff Comments Off on U.S. employment seen raising December rate hike chances
U.S. employment seen raising December rate hike chances
U.S. job growth likely accelerated in October after two straight months of tepid gains, with wages also picking up in a show of domestic strength that would bolster prospects for a December interest rate hike from the Federal Reserve. With speeches from several Fed officials, including Chair Janet Yellen, suggesting a low bar for a December rate increase, economists say job gains above 150,000 in October and November would be sufficient for the central bank to lift benchmark overnight borrowing costs from near zero. Minutes from the Fed’s Oct.
5 November, 2015 by The TZ Newswire Staff Comments Off on Pfizer-Allergan deal would set up U.S. company for a split
Pfizer-Allergan deal would set up U.S. company for a split
Many Wall Street analysts believe Pfizer will decide to split late next year, after compiling three years of financial data treating its “established products” division, which sells generic medicines, and its “innovative” patent-protected medicines unit, as if they were separate companies. “This would be the creation of two companies really, not one huge $350 billion Pfizer,” Andy Summers, co-portfolio manager at Janus Capital Group, said of the likely Pfizer split post merger.
5 November, 2015 by The TZ Newswire Staff Comments Off on Exclusive: Toshiba tries to sell down $7 billion U.S. gas commitment
Exclusive: Toshiba tries to sell down $7 billion U.S. gas commitment
TOKYO/MILAN (Reuters) – Japan’s Toshiba, struggling with a major accounting scandal, is trying to sell down a $7.4 billion commitment to U.S. liquefied natural gas (LNG), which it signed two years ago as part of a plan to sweeten sales of turbines for power plants. A plunge in Asian gas prices means an expected U.S. export bonanza has fizzled out before it even started, and has left the giant conglomerate potentially exposed to LNG processing fees of up to $370 million a year.
5 November, 2015 by The TZ Newswire Staff Comments Off on AstraZeneca agrees to buy ZS Pharma for $2.7 billion
AstraZeneca agrees to buy ZS Pharma for $2.7 billion
Britain’s AstraZeneca Plc (AZN.L) said on Friday it had agreed to buy ZS Pharma (ZSPH.O), paying a total $2.7 billion for its proprietary technology to develop novel treatments for hyperkalaemia, or high potassium levels. AstraZeneca said it had agreed to pay $90 a share for the San Mateo, California-based firm. Hyperkalaemia is typically associated with chronic kidney disease and chronic heart failure, AstraZeneca said, adding that peak sales of the company’s ZS-9 potassium-binding compound, which is under review by the FDA, were forecast to exceed $1 billion.
5 November, 2015 by The TZ Newswire Staff Comments Off on Active Biotech AB Interim report January – September 2015
Active Biotech AB Interim report January – September 2015
5 November, 2015 by The TZ Newswire Staff Comments Off on Trading Ideas – European session 6 Nov
Trading Ideas – European session 6 Nov
Yes folks, it’s the end of the week almost but not the end of our work yet
So as we digest the BOE fall-out and wait on what’s to follow post-NFPs let’s be having your trade ideas
5 November, 2015 by The TZ Newswire Staff Comments Off on Allianz profit down; PIMCO outflows lowest in 2 years
Allianz profit down; PIMCO outflows lowest in 2 years
German insurer Allianz posted a larger than expected 15 percent decline in net profit in the third quarter.